Key facts
- Active LCDs
- 190
- Contracts
- 15
- 10111, 10112, 10211, 10212, 10311, 10312, 11004, 11201, 11202, 11301, 11302, 11401, 11402, 11501, 11502
- States and territories
- 18
- AL AR FL GA IL IN KY LA MS NC NM OH OK SC TN TX VA WV
- Contractor site
- www.palmettogba.com
Jurisdictions
Contract numbers identify the jurisdiction on remittances and in the Medicare Coverage Database; A and B MAC contracts cover both institutional and professional claims, while DME and HHH contracts are national or regional specialty jurisdictions.
| Contract | Type | States |
|---|---|---|
| 10111 | A and B MAC | AL |
| 10112 | A and B MAC | AL |
| 10211 | A and B MAC | GA |
| 10212 | A and B MAC | GA |
| 10311 | A and B MAC | TN |
| 10312 | A and B MAC | TN |
| 11004 | A and B and HHH MAC | AL AR FL GA IL IN KY LA MS NC NM OH OK SC TN TX |
| 11201 | A and B and HHH MAC | SC |
| 11202 | A and B and HHH MAC | SC |
| 11301 | A and B and HHH MAC | VA |
| 11302 | A and B and HHH MAC | VA |
| 11401 | A and B and HHH MAC | WV |
| 11402 | A and B and HHH MAC | WV |
| 11501 | A and B and HHH MAC | NC |
| 11502 | A and B and HHH MAC | NC |
Most recently effective LCDs
Revision effective dates signal where this contractor has tightened or loosened criteria; the ten newest are listed first, with the full list below.
| LCD | Title | Effective |
|---|---|---|
| L40263 | Peripheral Nerve Injections and Procedures for Chronic Pain | 2026-10-25 |
| L40238 | MolDX: Genetic Testing for Hereditary Thrombophilia | 2026-10-12 |
| L40210 | MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Targeted Therapy in Cancer | 2026-10-12 |
| L40328 | Allergy Diagnostic Testing | 2026-09-27 |
| L39237 | Erythropoiesis Stimulating Agents | 2026-09-17 |
| L40058 | MolDX: Molecular Testing for Solid Organ Allograft Rejection | 2026-08-30 |
| L38026 | Corneal Hysteresis | 2026-08-13 |
| L40187 | MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis | 2026-08-10 |
| L39128 | Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound | 2026-07-16 |
| L40205 | Irreversible Electroporation for Cancer | 2026-07-05 |
All active LCDs (190)
- L38970 Advance Care Planning
- L40046 Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT)
- L40328 Allergy Diagnostic Testing
- L33417 Allergy Skin Testing
- L39270 Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin
- L39128 Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
- L39851 Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)
- L34410 B-type Natriuretic Peptide (BNP) Testing
- L37031 BDX-XL2
- L34411 Blepharoplasty, Eyelid Surgery, and Brow Lift
- L39268 Bone Mass Measurement
- L39836 Botulinum Toxin Injections
- L34415 CT of the Abdomen and Pelvis
- L34417 CT of the Head
- L33457 Cardiac Radionuclide Imaging
- L33423 Cardiac Computed Tomography & Angiography (CCTA)
- L39080 Cardiac Resynchronization Therapy (CRT)
- L34413 Cataract Surgery
- L38033 Cervical Disc Replacement
- L39773 Cervical Fusion
- L37387 Chiropractic Services
- L39266 Cognitive Assessment and Care Plan Service
- L38755 Colon Capsule Endoscopy (CCE)
- L34454 Colonoscopy/Sigmoidoscopy/Proctosigmoidoscopy
- L38769 Computed Tomography Cerebral Perfusion Analysis (CTP)
- L33459 Computerized Axial Tomography (CT), Thorax
- L37641 Continuous Peripheral Nerve Blocks (CPNB)
- L38026 Corneal Hysteresis
- L34512 Corneal Pachymetry
- L33428 Cosmetic and Reconstructive Surgery
- L38792 Dexamethasone Intracanalicular Ophthalmic Insert (Dextenza®)
- L37379 Echocardiography
- L38786 Echocardiography for Myocardial Perfusion
- L40228 Endovascular Management for Peripheral Arterial Disease of the Upper and Lower Extremities
- L38994 Epidural Steroid Injections for Pain Management
- L39237 Erythropoiesis Stimulating Agents
- L38775 Extracorporeal Shock Wave Therapy (ESWT)
- L38765 Facet Joint Interventions for Pain Management
- L34575 Frequency of Hemodialysis
- L36761 GlycoMark® Testing for Glycemic Control
- L33431 HbA1c
- L37638 Health and Behavior Assessment/Intervention
- L34561 Home Health - Psychiatric Care
- L34560 Home Health Occupational Therapy
- L34564 Home Health Physical Therapy
- L35132 Home Health Plans of Care: Monitoring Glucose Control in the Medicare Home Health Population with Type II Diabetes Mellitus
- L34562 Home Health Skilled Nursing Care-Teaching and Training: Alzheimer's Disease and Behavioral Disturbances
- L34563 Home Health Speech-Language Pathology
- L34565 Home Health-Surface Electrical Stimulation in the Treatment of Dysphagia
- L34419 Homocysteine Level, Serum
- L34544 Hospice - Liver Disease
- L34547 Hospice - Neurological Conditions
- L34559 Hospice - Renal Care
- L34567 Hospice Alzheimer's Disease & Related Disorders
- L34548 Hospice Cardiopulmonary Conditions
- L34558 Hospice The Adult Failure To Thrive Syndrome
- L39260 Hyaluronic Acid Injections for Knee Osteoarthritis
- L38276 Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea
- L38743 Implantable Continuous Glucose Monitors (I-CGM)
- L33461 Implantable Infusion Pump
- L34554 In Vitro Chemosensitivity & Chemoresistance Assays
- L35677 Infliximab
- L39942 Intervertebral Disc Repair
- L37779 Intraoperative Radiation Therapy
- L34580 Intravenous Immunoglobulin (IVIG)
- L40205 Irreversible Electroporation for Cancer
- L33420 Lab: Bladder/Urothelial Tumor Markers
- L37022 Lab: Coenzyme Q10 (CoQ10)
- L37581 Lab: Cystatin C Measurement
- L34513 Lab: Flow Cytometry
- L35922 Lab: Special Histochemical Stains and Immunohistochemical Stains
- L34576 Laparoscopic Sleeve Gastrectomy for Severe Obesity
- L39780 Lower Esophageal Magnetic Sphincter Augmentation
- L37826 Lumbar Artificial Disc Replacement
- L37848 Lumbar Spinal Fusion
- L39387 Luteinizing Hormone-Releasing Hormone (LHRH) Analogs
- L37602 MDS FISH
- L39400 Magnesium
- L34424 Magnetic Resonance Angiography
- L34425 Magnetic Resonance Imaging of the Head and Neck
- L37531 Micro-Invasive Glaucoma Surgery (MIGS)
- L39797 Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ)
- L33436 Mohs Micrographic Surgery (MMS)
- L40187 MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
- L36129 MolDX: Biomarkers in Cardiovascular Risk Assessment
- L38240 MolDX: Blood Product Molecular Antigen Typing
- L36125 MolDX: Breast Cancer Assay: Prosigna®
- L37794 MolDX: Breast Cancer Index® (BCI) Gene Expression Test
- L37033 MolDX: DecisionDx-UM (Uveal Melanoma)
- L37264 MolDX: EndoPredict Breast Cancer Gene Expression Test
- L37857 MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test
- L39636 MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers
- L40238 MolDX: Genetic Testing for Hereditary Thrombophilia
- L39933 MolDX: Genetic Testing for Heritable Thoracic Aortic Disease
- L36089 MolDX: Genetic Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR)
- L36464 MolDX: HLA-DQB1*06:02 Testing for Narcolepsy
- L37870 MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer
- L38966 MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
- L35974 MolDX: MGMT Promoter Methylation Analysis
- L37725 MolDX: Melanoma Risk Stratification Molecular Testing
- L38779 MolDX: Minimal Residual Disease Testing for Cancer
- L39345 MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma
- L39583 MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma
- L39424 MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis
- L39654 MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy
- L38985 MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
- L35025 MolDX: Molecular Diagnostic Tests (MDT)
- L38988 MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
- L39256 MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia
- L39935 MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis
- L39646 MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules
- L40058 MolDX: Molecular Testing for Solid Organ Allograft Rejection
- L35073 MolDX: NRAS Genetic Testing
- L38047 MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
- L38045 MolDX: Next-Generation Sequencing for Solid Tumors
- L40210 MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Targeted Therapy in Cancer
- L39919 MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
- L36912 MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™)
- L38294 MolDX: Pharmacogenomics Testing
- L38566 MolDX: Phenotypic Biomarker Detection in Circulating Tumor Cells
- L38051 MolDX: Pigmented Lesion Assay
- L38043 MolDX: Plasma-Based Genomic Profiling in Solid Tumors
- L38238 MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer
- L38576 MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
- L37260 MolDX: Prometheus® IBD sgi Diagnostic® Policy
- L38292 MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease
- L38274 MolDX: Repeat Germline Testing
- L39385 Near-Infrared Spectroscopy in Wound and Flap Management
- L37642 Nerve Blocks and Electrostimulation for Peripheral Neuropathy
- L35048 Nerve Conduction Studies and Electromyography
- L38278 Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease
- L33438 Octreotide Acetate for Injectable Suspension (Sandostatin® LAR Depot)
- L34551 One Day Stays for Chest Pain
- L34426 Ophthalmic Angiography (Fluorescein and Indocyanine Green)
- L33467 Ophthalmology: Extended Ophthalmoscopy and Fundus Photography
- L39849 Opioid Treatment Programs
- L34552 Outpatient Observation Bed/Room Services
- L34427 Outpatient Occupational Therapy
- L34428 Outpatient Physical Therapy
- L39853 Outpatient Psychotherapy
- L34429 Outpatient Speech Language Pathology
- L37633 Partial Hospitalization Programs
- L38737 Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF)
- L40263 Peripheral Nerve Injections and Procedures for Chronic Pain
- L38747 Peroral Endoscopic Myotomy (POEM)
- L38745 Platelet Rich Plasma
- L36593 Polysomnography
- L36665 ProMark® Risk Score
- L34570 Psychiatric Inpatient Hospitalization
- L33444 Pulmonary Stress Testing
- L39553 Radiation Therapies
- L33445 Removal of Benign and Malignant Skin Lesions
- L34869 Repetitive Transcranial Magnetic Stimulation (rTMS) in Adults
- L34430 Respiratory Therapy (Respiratory Care)
- L33446 Respiratory Therapy and Oximetry Services
- L34577 Retroperitoneal Ultrasound
- L35026 Rituximab
- L37643 Routine Foot Care
- L39543 Sacral Nerve Stimulation for the Treatment of Urinary and Fecal Incontinence
- L39402 Sacroiliac Joint Injections and Procedures
- L39573 Scalp Cooling for the Prevention of Chemotherapy-Induced Alopecia
- L34431 Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)
- L34433 Somatosensory Testing
- L33447 Special Electroencephalography
- L37632 Spinal Cord Stimulators for Chronic Pain
- L34553 Stretta Procedure
- L40189 Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)
- L37774 Supervised Exercise Therapy for the Treatment of Peripheral Arterial Disease with Symptomatic Lower Extremity Intermittent Claudication
- L34578 Surface Electrical Stimulation in the Treatment of Dysphagia
- L39258 Surgical Treatment of Nails
- L33449 Swallowing Studies for Dysphagia
- L40257 Temporary Nontherapeutic Ambulatory Cardiac Monitoring Devices
- L39420 Thermal Destruction of the Intraosseous Basivertebral Nerve (BVN) for Vertebrogenic Lower Back Pain
- L37873 Topical Oxygen Therapy
- L33456 Total Joint Arthroplasty
- L39956 Total Shoulder Arthroplasty
- L38551 Transanal Endoscopic Surgery (TES)
- L38549 Transurethral Waterjet Ablation of the Prostate
- L39086 Treatment of Males with Low Testosterone
- L39121 Treatment of Varicose Veins of the Lower Extremities
- L39671 Trigger Point Injections (TPI)
- L34434 Upper Gastrointestinal Endoscopy and Visualization
- L35724 Urine Drug Testing
- L34537 Vestibular Function Testing
- L39391 Vitamin D Assay Testing
- L37863 Voretigene Neparvovec-rzyl (Luxturna®)
- L37176 White Cell Colony Stimulating Factors
- L36427 Wireless Capsule Endoscopy
- L33455 Wireless Gastrointestinal Motility Monitoring Systems
- L37644 YAG Capsulotomy
How to use this contractor's policies
A Local Coverage Determination applies only to claims processed by the contractor that wrote it, so the first question is which jurisdiction the rendering location falls in; the contracts table above answers that for institutional and professional claims, and durable medical equipment follows the DME MAC region instead. Each LCD states the covered indications, the documentation the record must contain and, through its companion Billing and Coding Article, the ICD-10 codes that support medical necessity and the HCPCS codes the policy edits. When a claim denies with CARC 50 and remark N115, the remark names the LCD; open it from the list above, compare the diagnosis on the claim with the article's covered list, and build the appeal on the documentation requirements rather than on the policy itself. Where this contractor has no LCD for a service and no National Coverage Determination exists, coverage is decided claim by claim under the reasonable-and-necessary standard, which is where prior authorization and pre-service review earn their keep.
Frequently asked questions
Which states does Palmetto GBA cover?
Palmetto GBA holds 15 Medicare contracts (10111 A and B MAC; 10112 A and B MAC; 10211 A and B MAC; 10212 A and B MAC; 10311 A and B MAC; 10312 A and B MAC; 11004 A and B and HHH MAC; 11201 A and B and HHH MAC; 11202 A and B and HHH MAC; 11301 A and B and HHH MAC; 11302 A and B and HHH MAC; 11401 A and B and HHH MAC; 11402 A and B and HHH MAC; 11501 A and B and HHH MAC; 11502 A and B and HHH MAC) covering AL, AR, FL, GA, IL, IN, KY, LA, MS, NC, NM, OH, OK, SC, TN, TX, VA, WV.
How many LCDs does Palmetto GBA have?
190 Local Coverage Determinations are active in the current Medicare Coverage Database export for Palmetto GBA. Each LCD applies only in that contractor's jurisdiction, so the same service can be covered differently in a neighbouring state.
What is the difference between an LCD and an NCD?
A National Coverage Determination is set by CMS and binds every contractor. A Local Coverage Determination is written by one Medicare Administrative Contractor for its jurisdiction and cannot conflict with an NCD; where no NCD exists, the LCD is the controlling policy.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-02. Verify against the primary file before billing or contracting decisions.
- Medicare Coverage Database, current LCD exportVersion MCD release 2026-09-24 · effective 2026-09-20 · file lcd.csvSHA-256 2fcc4251b6ddd1eb…
Disclaimer
Contractor jurisdictions and LCD lists are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify coverage against the current LCD text on cms.gov or the contractor site before billing. Not legal, clinical or billing advice.